Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer
about
Irreversible electroporation: state of the artMultiparametric prostate magnetic resonance imaging in the evaluation of prostate cancerIrreversible ElectroporationFocal therapy as primary treatment for localized prostate cancer: definition, needs and future.Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic review.Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.Emerging minimally invasive procedures for focal treatment of organ-confined prostate cancer.An update on focal therapy for prostate cancer.Optimization of Irreversible Electroporation Protocols for In-vivo Myocardial Decellularization.Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies.Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.Histological and Mathematical Analysis of the Irreversibly Electroporated Liver Tissue.MRI-guided biopsies and minimally invasive therapy for prostate cancer.Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedbackFocal irreversible electroporation as primary treatment for localized prostate cancer.Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate.Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.Multi-parametric MRI imaging of the prostate-implications for focal therapy.Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate CancerPatient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance.[Focal therapy of prostate cancer].[Focal therapy for prostate cancer: German version].[Focal therapy of prostate cancer in Germany].[Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer].The prostate cancer focal therapy.Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and CryotherapyImpact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segmentsHigh-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model
P2860
Q26746226-8F470BE2-6415-470E-94E8-4BC60F10B64EQ26776478-9AC0F69F-0EAA-4055-86B9-6DC4FB87571FQ28082560-B76AD4A9-440C-4BC3-857B-2660D4595D50Q30240753-549ED2BE-8EF2-4B48-AEFE-73CAD896B16FQ30241856-13AF2B56-3C7B-4925-BBE8-3007AC322623Q36009979-44F18FB5-4F5C-4C97-BAF2-7CDE1ACD09AFQ36065097-E8B90013-8AFB-4769-8F5F-0DDB378E10A9Q36145325-CB0B6007-91EE-4328-B165-F3B9C6687ED1Q37445983-2B9E3E29-206D-4FF6-8535-5835C247C5EDQ37595430-279792A3-0FA4-449B-9F1F-D3C43A9E7468Q37685261-85D44B93-E3C0-48B0-8F5E-E7E05F987FDFQ38307414-863665EE-6AB3-4FA2-9EE1-48C66519F175Q38415375-674924C7-1C76-4978-B660-A02ADD031518Q38545811-11FC8481-28D9-402C-980A-793C3D90D245Q38611750-AA9BA615-14E8-4289-9F7E-6D575F717DB6Q38613435-F61627B5-3790-48FC-A454-9FD83C6F3B4BQ38630336-08B8B12E-9C59-4C29-8354-C7E27F5B47ACQ38683500-4F09CA9E-A200-43F0-B099-1696373DD107Q38739753-998C7C20-D931-440C-93F5-6D00692EC863Q38826188-AE8A5441-38F1-44C8-A025-FC60400EBF66Q39422186-4047B76A-586E-48A0-9DCD-92E7D62E7865Q39438297-CC6CD3F2-DDD4-449B-A55E-446E7C6B52A3Q39446420-831E1A49-85BD-4CCA-8C11-B080D1D029E6Q40440753-A6D61CE5-D3F5-41F2-B2A4-5D3EE34C9A66Q40699570-5664FF17-CAF3-4D30-936F-31F9BBACAB3BQ50020871-92484F5F-C12E-4BE2-B4F8-CF17BAE2184DQ50239157-EAE00B0A-E652-43E0-8F65-A386A242B404Q50241890-34F2DFFD-A7A7-4697-9C9D-44AC205C405AQ53108923-9FE56C76-81E0-4585-8475-DF1680869D76Q53310174-BE94F06F-F8A6-40E6-8205-D0A1C2FD3F33Q54996559-68C58FB7-39EC-4E05-9E95-016E3F029A8DQ57118596-F3A9CB02-C78A-4FB5-9051-612075CC4045Q58784302-AEA3F5A2-DBB1-46A6-BA2E-DCE2FF73F1B2Q58803526-1C179190-E993-4C5B-8300-6CC09D6EA516
P2860
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Initial assessment of safety a ...... l treatment of prostate cancer
@ast
Initial assessment of safety a ...... l treatment of prostate cancer
@en
Initial assessment of safety a ...... l treatment of prostate cancer
@nl
type
label
Initial assessment of safety a ...... l treatment of prostate cancer
@ast
Initial assessment of safety a ...... l treatment of prostate cancer
@en
Initial assessment of safety a ...... l treatment of prostate cancer
@nl
prefLabel
Initial assessment of safety a ...... l treatment of prostate cancer
@ast
Initial assessment of safety a ...... l treatment of prostate cancer
@en
Initial assessment of safety a ...... l treatment of prostate cancer
@nl
P2093
P2860
P356
P1476
Initial assessment of safety a ...... l treatment of prostate cancer
@en
P2093
L Dickinson
M Emberton
P2860
P2888
P304
P356
10.1038/PCAN.2014.33
P577
2014-09-02T00:00:00Z